GSK 424887Alternative Names: 424887; GSK424887
Latest Information Update: 03 Jan 2014
At a glance
- Originator GlaxoSmithKline
- Class Antidepressants; Anxiolytics
- Mechanism of Action Neurokinin 1 receptor antagonists; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder